ArticleBMC pulmonary medicine2023

A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients.

Xilin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.